Ontrak, INC 8-K filings

Ontrak, Inc. announced its board of directors approved a voluntary petition for Chapter 7 bankruptcy, leading to the immediate resignation of all board members.

Ontrak, Inc. received a delisting notice from Nasdaq due to failing the minimum bid price rule and being deemed a public shell, following its decision to cease operations.

Ontrak, Inc. announced its board of directors decided to cease operations and terminate all employees, including executive officers, effective July 31, 2025, due to a significant sales prospect withdrawal and inability to secure further funding.

Ontrak, Inc. announced that a significant prospect, representing up to 29,000 potential lives across its Wholehealth+ and Engage programs, has decided not to pursue a partnership, citing financial stability and program delivery concerns.

Ontrak, Inc. has successfully closed a public offering raising approximately $3.24 million in net proceeds through the sale of common stock, pre-funded warrants, and common warrants, earmarked for working capital and general corporate purposes.

Ontrak, Inc. has entered into a Seventh Amendment to its Master Note Purchase Agreement with Acuitas Capital LLC, securing a commitment for up to $8.45 million in senior secured convertible promissory notes and potentially more, while also adjusting terms for existing warrants, leading to substantial shareholder dilution.

Ontrak Health reports a 25% year-over-year decrease in Q1 2025 revenue, alongside a $10 million financing commitment from Acuitas Capital LLC.

Ontrak, Inc. enters into an agreement with Acuitas Capital for up to $10 million in financing through senior secured promissory notes.

Ontrak Health announces its Q4 and full-year 2024 financial results, highlighting revenue declines but improvements in operating and adjusted EBITDA losses, along with new customer partnerships and contract extensions.

Ontrak, Inc. has announced a new agreement with Intermountain Health and increased forecasts from existing customers, projecting a 25% rise in annualized revenue.

Ontrak Health's Q3 2024 results show a revenue decrease of 31% year-over-year, alongside an operating loss increase of 26%, while the company expands its behavioral health solutions and announces a reverse stock split.

Ontrak, Inc. has expanded its strategic partnership with an existing customer, projecting a 20% increase in annualized revenue from that customer.

Ontrak, Inc. amended warrants to lower the exercise price, resulting in $1.5 million in proceeds and regained compliance with Nasdaq's minimum bid price rule.

Ontrak, Inc. has been notified by a major health plan customer that they will not be renewing their contract, which will significantly impact the company's revenue.

Ontrak Inc. will implement a 1-for-15 reverse stock split effective September 23, 2024, to increase its stock price and regain compliance with Nasdaq's minimum bid price requirement.

Ontrak, Inc. stockholders approved an amended stock incentive plan, the election of directors, the ratification of the company's accounting firm, and a potential reverse stock split at their annual meeting on September 10, 2024.

Ontrak Health reported a 17% year-over-year revenue decrease for Q2 2024, alongside a new contract with a large northeast regional health plan.

Ontrak has been granted a temporary exception by Nasdaq to avoid delisting, contingent on shareholder approval and implementation of a reverse stock split by September 23, 2024, and achieving a minimum share price of $1.00 by October 7, 2024.

Ontrak Health announced its Q1 2024 financial results, showing a 6% increase in revenue year-over-year and significant improvements in operating loss and adjusted EBITDA.

Ontrak's fourth quarter revenue increased by 41% year-over-year, while full-year revenue decreased by 12%, and the company secured significant financing through a public offering and debt conversions.

Ontrak Inc. has adjusted the exercise price of its November 2023 warrants to $0.3442 per share, following the execution of the Sixth Amendment to its Master Note Purchase Agreement.

Ontrak, Inc. has entered into a sixth amendment to its Master Note Purchase Agreement, securing an initial $1.5 million in funding and potentially up to an additional $13.5 million, while also adjusting warrant terms.